About Forendo Pharma
Forendo Pharma is a company based in Turku (Finland) founded in 2013 was acquired by Organon in November 2021. Forendo Pharma has raised $25.58 million across 5 funding rounds from investors including Finnvera, Business Finland and Karolinska Development. Forendo Pharma operates in a competitive market with competitors including Sprout Pharmaceuticals, Hope Medicine, Rejoni, ObsEva and Gameto, among others.
- Headquarter Turku, Finland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Forendo Pharma
Forendo Pharma has successfully raised a total of $25.58M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $5.62 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $5.6M
- First Round First Round
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series A - Forendo Pharma | Valuation | Sunstone | |
| Sep, 2018 | Amount | Series A - Forendo Pharma | Valuation | Vesalius Biocapital III |
|
| Mar, 2018 | Amount | Debt – Conventional - Forendo Pharma | Valuation |
investors |
Investors in Forendo Pharma
Forendo Pharma has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Finnvera, Business Finland and Karolinska Development.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by Sunstone in early-stage European companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investments are made in innovative life science companies globally.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Forendo Pharma
Financial Statements - Forendo Pharma
Forendo Pharma Comparisons
Competitors of Forendo Pharma
Forendo Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, Hope Medicine, Rejoni, ObsEva and Gameto, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for fertility and menopause treatments are developed.
|
Frequently Asked Questions about Forendo Pharma
Forendo Pharma was founded in 2013.
Forendo Pharma is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.
Forendo Pharma is a funded company, having raised a total of $25.58M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $3.69M, raised on Jun 25, 2013.
Forendo Pharma was founded in 2013 in Turku, Finland, and operates in the biotechnology sector focused on reproductive health. Small molecule therapeutics are developed by the company to regulate sex hormone effects in a tissue-specific manner. The pipeline includes Fispemifene, a selective estrogen receptor modulator in phase II trials for male hypogonadism, and an HSD17B1 enzyme inhibitor under investigation for endometriosis treatment.
Forendo Pharma's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Forendo Pharma has 11 investors. Key investors include Finnvera, Business Finland, Karolinska Development, MSVentures, and Sunstone.